Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Cancer de Mama en Mexico Mitos y Real Ida Des
Cancer de Mama en Mexico Mitos y Real Ida Des
REFERENCIAS
1. Ferlay J, Bray F, Pisani P & Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality
and Prevalence worlwide. International Agency for Research on Cancer. World Health
Organization. Lyon, IARC Press 2002
2. Mettlin C. Global Breast Cancer Mortality Statistics. CA Cancer J Clin 1999;49:138-44
3. Parker D, Muir C, Whelan S. eds. Cancer Incidence in Five Continents, 1986-1989.
International Agency for Research on Cancer and International Association of Cancer
Registries. IARC Scientific publication N° 20, Lyon France, 1992
4. Compendio del Registro Histopatológico de Neoplasias en México. Morbilidad y
Mortalidad 1999. Secretaria de Salud.
5. Rodríguez-Cuevas SA, Labastida AS, Tapia R, Kuri P, Macías C. Registro
histopatológico de Neoplasias en México. Población derechohabiente del IMSS 1991-
1996. Ciencia y Cultura Latinoamericana, México D.F. 1999;56
6. Ziegler RG, Hoover RN, Pike MC et al. Migration patterns and breast cancer risk in Asian-
American women. J Natl Cancer Inst 1993;85:1819-27
7. Aceves EA. Boletín trimestral del Johnson & Johnson Medical Mexico, 2003;3:7
8. Parker SL, Tong T, Bolden S, et al. Cancer Statistics, 1997. CA Cancer J Clin 1997;47:5-
27
9. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, eds. SEER Cancer Statistics
Review, 1973-1995. National Cancer Institute, Bethesda, MD, 1998
10. Sondik EJ. Breast cancer trends: Incidence, mortality and survival. Cancer 1994;74;995-
99
11. Garfinkel L, Boring CC, Heath CW. Changing trends: An overview of breast cancer
incidence and mortality. Cancer 1994;74:222-27
12. White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in
relation to mammography use. J Natl Cancer Inst 1990;82:1546-52
13. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and
the relevance of early detection: An update. CA Cancer J Clin 1993;43:27-41
Rodríguez-Cuevas S.A. 15
14. Chu KC, Tarone R, Kessler L et al. Recent trends in US breast cancer incidence, survival
and mortality rates. J Natl Cancer Inst 1996;88:1571-9
15. La Vecchia C, Negri E, Levi F, Decarli A. Age, Cohort of birth, and period of death trends
in breast cancer mortality in Europe. J Natl Cancer Inst 1997;89:732-4
16. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer Statistics 2006.
JNCCN 2006 ;4(5):480-508
17. Rodríguez-Cuevas S, Macías CG, Franceschi D, Labastida S. Breast Carcinoma
presents a decade earlier in Mexican women than in women in the United Status or
European countries. Cancer 2001;91:863-8
18. Rodríguez-Cuevas S, Huerta BJ, Labastida AS. Tratamiento de las etapas III del cáncer
de mama. Cir Gral 1997;19:211-5
19. Blot WJ, McLaughlin JK. Geographic patterns of breast cancer among American women
(editorial). J Natl Cancer Inst 1995:87:1819-20
20. Peña-Gómez RM. Edad de la menarquia en tres grupos de niñas mexicanas.
Departamento de Investigaciones antropológicas. INAH. Publicación 24. Secretaría de
Educación Pública, México D.F. 1970
21. Rossouw JE, Anderson GL, Prentice RL et al. Writing group for the Women’s Health
Initiative Investigators: Risks and benefits of estrogen plus progestins in menopausal
women: Principal results from the Women’s Health Initiative randomized controlled trial.
JAMA 2002;288:321-33
22. Barclay L. More evidence linking estrogen plus progestin therapy to breast cancer. JAMA
2003;289:3243-53, 3254-63, 3304-06
23. World Health Organization Databank
24. Tominaga S, Kuroishi T, Aoki K. Cancer mortality statistics in 33 countries. International
Union Against Cancer. Geneva, 1998
25. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol VII IARC
publication N° 143, Lyon, France 1997
26. Bland KI, Menck HR, Scott-Conner CE. Et al. The National Cancer Database. 10 year
survey of breast cancer treatment at hospitals in the United States. Cancer
1998;83:1262-73
Rodríguez-Cuevas S.A. 16
Cáncer de Mama
Incidencia y Mortalidad por Tipo de Tumor
(mujeres)
Mama
Cérvix
Colon/Recto
Pulmón
Estómago
Ovario
Utero Incidencia
Hígado Mortalidad
Esófago
Linfoma no Hodgkin
Leucemia
0 10 20 30 40
Bajo 5.89-11.25
Medio 11.26-16.62
Alto 16.63-22
NACIONAL: 14.58
Fuente: INEGI/CONAPO
Cáncer de Mama
a
En todo el mundo en el 2002
• 1.15 millónes de nuevos casos (>10% de todos los
Ca.)
• 410,000 muertes (30%); 1º lugar en mujeres
15.5
Tasa por 100,000 mujeres
15
14.58
de 25 y mas años
14.5
14
13.5
13
12.5
13.06
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Fuente: INEGI/CONAPO
CÁNCER DE MAMA
En Méxicoa
E D A D -IN S T IT U C IO N < 20
20-29
9000
30-39
8000
40-49
7000
50-59
6000
60-69
5000
70 y >
4000
3000
2000
1000
0
60- 70 y
40- 50-
30- 69 >
< 20 20- 59
39 49
29
1990
10,779,771
2000
16,942,571
2003
17,049.036
2010
22,323,064
2020
29,702,037
500
Casos
400
300
200
100
0
0 I II A II B III A III B IV N/C
FUENTE: DGSR